University of Washington Muscle Gene Regulatory Cassettes Patent Application EP4319874A2
Summary
The European Patent Office published patent application EP4319874A2 for University of Washington covering artificial regulatory cassettes for muscle-specific gene expression. The application names inventors Jeffrey S. Chamberlain and Stephen D. Hauschka. The patent is classified under IPC codes related to genetic engineering and pharmaceutical preparations for muscular disorders.
What changed
The EPO published application EP4319874A2 discloses genetic constructs designed to drive expression of therapeutic genes specifically in muscle tissue. The regulatory cassettes incorporate promoter and enhancer elements for targeted gene expression.
For parties in the biotechnology and pharmaceutical sectors, this publication establishes a public record of University of Washington's intellectual property claims in muscle-targeted gene therapy. Competitors developing similar gene expression systems should review the claims upon grant to assess potential freedom-to-operate implications.
Archived snapshot
Apr 19, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
ARTIFICIAL REGULATORY CASSETTES FOR MUSCLE-SPECIFIC GENE EXPRESSION
Publication EP4319874A2 Kind: A2 Apr 08, 2026
Applicants
University of Washington
Inventors
CHAMBERLAIN, Jeffrey S., HAUSCHKA, Stephen D.
IPC Classifications
A61P 21/00 20060101AFI20250417BHEP C12N 15/66 20060101ALI20250417BHEP C12N 15/67 20060101ALI20250417BHEP C12N 15/85 20060101ALI20250417BHEP C12N 15/861 20060101ALI20250417BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Related changes
Get daily alerts for EPO Patent Bulletin - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Biotech (C12N) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.